Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay J Mathew

Showing results (11-20 of 189) with videos related to

Pageof 19
Sort By:
Advances in Pharmacology (San Diego, Calif.)|July 4, 2020
Ketamine for depression clinical issuesSyed Z Iqbal, Sanjay J Mathew
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Anxiety disorders: a comprehensive review of pharmacotherapiesEllen J Hoffman, Sanjay J Mathew
The American Journal of Psychiatry|February 4, 2020
Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring ChangeSanjay J Mathew, Rebecca B Price
The American Journal of Psychiatry|March 1, 2023
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic LandscapeManish K Jha, Sanjay J Mathew
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2023
The why, when, where, how, and so what of so-called rapidly acting antidepressantsAlan F Schatzberg, Sanjay J Mathew
Chronic Stress (Thousand Oaks, Calif.)|July 6, 2019
"Does the opioid system block or enhance the antidepressant effects of ketamine?"Sanjay J Mathew, Ana Maria Rivas-Grajales
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 15, 2005
Glutamate modulators as novel interventions for mood disordersSanjay J Mathew, Kathryn Keegan, Lisa Smith
The New England Journal of Medicine|September 6, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. ReplyAmit Anand, Sanjay J Mathew, Bo Hu
Expert Opinion on Drug Safety|March 7, 2022
A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depressionAmanda Tamman, Amit Anand, Sanjay J Mathew
The Mount Sinai Journal of Medicine, New York|January 2, 2007
Neurobiology of anxiety disorders and implications for treatmentAmir Garakani, Sanjay J Mathew, Dennis S Charney
Pageof 19

Showing results (11-20 of 189) with videos related to

Sort By:
Pageof 19
Advances in Pharmacology (San Diego, Calif.)|July 4, 2020
Ketamine for depression clinical issuesSyed Z Iqbal, Sanjay J Mathew
The Mount Sinai Journal of Medicine, New York|August 16, 2008
Anxiety disorders: a comprehensive review of pharmacotherapiesEllen J Hoffman, Sanjay J Mathew
The American Journal of Psychiatry|February 4, 2020
Ketamine Plus Motivational Enhancement Therapy: Leveraging a Rapid Effect to Promote Enduring ChangeSanjay J Mathew, Rebecca B Price
The American Journal of Psychiatry|March 1, 2023
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic LandscapeManish K Jha, Sanjay J Mathew
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 17, 2023
The why, when, where, how, and so what of so-called rapidly acting antidepressantsAlan F Schatzberg, Sanjay J Mathew
Chronic Stress (Thousand Oaks, Calif.)|July 6, 2019
"Does the opioid system block or enhance the antidepressant effects of ketamine?"Sanjay J Mathew, Ana Maria Rivas-Grajales
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|October 15, 2005
Glutamate modulators as novel interventions for mood disordersSanjay J Mathew, Kathryn Keegan, Lisa Smith
The New England Journal of Medicine|September 6, 2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. ReplyAmit Anand, Sanjay J Mathew, Bo Hu
Expert Opinion on Drug Safety|March 7, 2022
A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depressionAmanda Tamman, Amit Anand, Sanjay J Mathew
The Mount Sinai Journal of Medicine, New York|January 2, 2007
Neurobiology of anxiety disorders and implications for treatmentAmir Garakani, Sanjay J Mathew, Dennis S Charney
Pageof 19